{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:18:42Z","timestamp":1770815922447,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.schres.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T05:35:08Z","timestamp":1321421708000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia"],"prefix":"10.1016","volume":"134","author":[{"given":"Dawn","family":"Velligan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Sicuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Walling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Riesenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adonis","family":"Sfera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Merideth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2011.10.004_bb0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/schbul\/sbp068","article-title":"When top\u2013down meets bottom\u2013up: auditory training enhances verbal memory in schizophrenia","volume":"35","author":"Adcock","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.10.004_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0091-3057(95)00119-H","article-title":"Nicotine enhances the learning and memory of aged rats","volume":"52","author":"Arendash","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2011.10.004_bb0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/schbul\/sbn037","article-title":"CNTRICS Executive Committee. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative","volume":"34","author":"Barch","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.10.004_bb0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1176\/appi.ajp.157.4.549","article-title":"Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates","volume":"157","author":"Bilder","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0025","first-page":"608","article-title":"Treatment of cognitive deficits in schizophrenia","volume":"7","author":"Bowie","year":"2006","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.schres.2011.10.004_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.10.004_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.NMD.0000050937.06332.3C","article-title":"Initial and final work performance in schizophrenia: cognitive and symptom predictors","volume":"191","author":"Bryson","year":"2003","journal-title":"J. Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.schres.2011.10.004_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopsych.2011.01.041","article-title":"Cognitive neuroscience treatment research to improve cognition in schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders","volume":"70","author":"Carter","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 18","key":"10.1016\/j.schres.2011.10.004_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000297067","article-title":"Childhood attentional dysfunction predicts social deficits in unaffected adults at risk for schizophrenia","volume":"161","author":"Cornblatt","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0050","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","article-title":"Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alphabungarotoxin and nicotine binding in the thalamus","volume":"73","author":"Court","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.schres.2011.10.004_bb0055","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"155","author":"Dalack","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0060","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00213-006-0675-x","article-title":"Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers","volume":"191","author":"Dunbar","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2011.10.004_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects","volume":"10","author":"Gatto","year":"2004","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.schres.2011.10.004_bb0075","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.149.9.1189","article-title":"Cigarette smoking in schizophrenia: relationship psychopathology and medication side effects","volume":"149","author":"Goff","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2011.10.004_bb0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/schbul\/sbm074","article-title":"Molecular targets for treating cognitive dysfunction in schizophrenia","volume":"33","author":"Gray","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.10.004_bb0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.10.004_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.10.004_bb0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.1996.01830110060007","article-title":"Life prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis in a US community sample: the National Comorbidity Survey","volume":"53","author":"Kendler","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.schres.2004.09.004","article-title":"NIMH-MATRICS survey on assessment of neurocognition in schizophrenia","volume":"72","author":"Kern","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.10.004_bb0110","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self medication hypotheses","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2011.10.004_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0163-1047(92)90399-O","article-title":"Persistence of chronic nicotine-induced cognitive facilitation","volume":"58","author":"Levin","year":"1992","journal-title":"Behav. Neural. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2011.10.004_bb0120","first-page":"258","article-title":"Relationships between test and factor scores, and psychometric properties: the matrics consensus cognitive battery (MCCB) and the IntegNeuro computerized battery in schizophrenia","volume":"35","author":"Malinovsky","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.10.004_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.schres.2004.09.010","article-title":"Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia","volume":"72","author":"Marder","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.10.004_bb0130","series-title":"Clinical Handbook of Schizophrenia","author":"Mueser","year":"2008"},{"key":"10.1016\/j.schres.2011.10.004_bb0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-3223(00)01094-5","article-title":"Cognitive effects of nicotine","volume":"49","author":"Rezvani","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.004_bb0140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/13803391003596496","article-title":"A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries","volume":"32","author":"Silverstein","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2011.10.004_bb0145","doi-asserted-by":"crossref","first-page":"T54","DOI":"10.1016\/j.neuroimage.2007.03.018","article-title":"fMRI studies of eye movement control: investigating the interaction of cognitive and sensorimotor brain systems","volume":"36","author":"Sweeney","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.schres.2011.10.004_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(97)00010-8","article-title":"The functional significance of symptomatology and cognitive function in schizophrenia","volume":"25","author":"Velligan","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.10.004_bb0155","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1037\/0894-4105.19.6.778","article-title":"No, it is not possible to be schizophrenic yet neuropsychologically normal","volume":"19","author":"Wilk","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1016\/j.schres.2011.10.004_bb0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4088\/JCP.v66n0906","article-title":"The economic burden of schizophrenia in the United States in 2002","volume":"66","author":"Wu","year":"2005","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411005391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411005391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:23:20Z","timestamp":1760297000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411005391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0920996411005391"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.10.004","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2011.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}